Claritas Pharmaceuticals Inc V.CLAS.H

RE:Nitric Oxide News, SaNOtize

[Red~One]

“As we grapple with waning vaccine efficacy, mixed results from antiviral drugs and evolving variants of concern, there is an increasing need for effective and safe COVID-19 therapies,” said study author and SaNOtize Chief Scientific Officer and Co-Founder, Chris Miller, PhD.

“To our knowledge, no other outpatient antiviral therapy has led to negative PCR conversion as quickly as NONS. The study data demonstrate the use of NONS to treat people with COVID-19 who are at risk for disease progression. The fact that NONS was effective, well tolerated, and rapidly reduced viral load suggests it may be a powerful weapon in the armamentarium required to manage COVID-19 and prevent future outbreaks.”